5 medtech funding insights you need to know

Venture capital funding isn’t what it used to be for medical device startups, but there are actually reasons to feel optimistic about medtech funding.

That was the big takeaway from a four-expert panel at DeviceTalks Minnesota last month. (The next DeviceTalks is Oct. 2 in Boston.)

Charlie Whelan, director of transformational health consulting at Frost & Sullivan, led a discussion with Anne Sissel, managing director for Baxter Ventures; Kathleen Tune, an advisor at Thomas, McNerney & Partners; and Dr. Dennis Wahr, president and CEO of Nuvaira.

Here are five important insights that came out of the discussion.

Next>>

[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]